Immunoglobulin M oligoclonal bands: Biomarker of targetable inflammation in primary progressive multiple sclerosis-Reference-Cited by-同舟云学术

Immunoglobulin M oligoclonal bands: Biomarker of targetable inflammation in primary progressive multiple sclerosis

Published:2014-07-02 Issue:2 Volume:76 Page:231-240
ISSN:0364-5134
Container-title:Annals of Neurology
language:en
Short-container-title:Ann Neurol.

Author:

Villar Luisa M.¹,Casanova Bonaventura²,Ouamara Nadia³,Comabella Manuel⁴,Jalili Farzaneh⁵,Leppert David⁶,de Andrés Clara⁷,Izquierdo Guillermo⁸,Arroyo Rafael⁹,Avşar Timuçin¹⁰,Lapin Sergey V.¹¹,Johnson Trina³,Montalbán Xavier⁴,Fernández Oscar¹²,Álvarez-Lafuente Roberto⁹,Masterman Donna⁶,García-Sánchez María I.⁸,Coret Francisco¹³,Siva Aksel¹⁴,Evdoshenko Evgeniy¹⁵,Álvarez-Cermeño José C.¹¹⁶,Bar-Or Amit³⁵

Affiliation:

1. Immunology and Neurology Service; Multiple Sclerosis Unit, Ramón y Cajal University Hospital; Madrid Spain

2. Multiple Sclerosis Unit; La Fe University and Polytechnic Hospital; Valencia Spain

3. Experimental Therapeutics Program, Montreal Neurological Institute and Hospital, McGill University; Montreal Quebec Canada

4. Neurological/Neuroimmunological Service; Multiple Sclerosis Center of Catalonia, Vall d'Hebron University Hospital; Barcelona Spain

5. Neuroimmunology Unit; Montreal Neurological Institute and Hospital, McGill University; Montreal Quebec Canada

6. F. Hoffman-La Roche; Basel Switzerland

7. Neurology Service; Gregorio Marañón University Hospital; Madrid Spain

8. Neurology Service; Virgen Macarena University Hospital; Seville Spain

9. Neurology Service; Health Research Institute of the San Carlos Clinical University Hospital; Madrid Spain

10. Genetics and Biotechnology Program; Department of Molecular Biology; Istanbul Technical University; Istanbul Turkey

11. Center for Molecular Medicine; Pavlov State Medical University; St Petersburg Russia

12. Neurology Service; Regional University Hospital of Málaga; Málaga Spain

13. Neurology Service; Clinical University Hospital; Valencia Spain

14. Department of Neurology; Cerrahpaşa School of Medicine, Istanbul University; Istanbul Turkey

15. St Petersburg Center for Multiple Sclerosis and Autoimmune Diseases; City Hospital; St Petersburg Russia

16. Department of Medicine; University of Alcalá de Henares; Madrid Spain

Funder

Multiple Sclerosis Society of Canada - Research Foundation

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ana.24190/fullpdf

Reference35 articles.

1. Glatiramer acetate in primary progressive multiple sclerosis: results of a multinational, multicenter, double-blind, placebo-controlled trial;Wolinsky;Ann Neurol,2007

2. Rituximab in patients with primary progressive multiple sclerosis. Results of a randomized double-blind placebo-controlled multicenter trial;Hawker;Ann Neurol,2009

3. Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria.”;Polman;Ann Neurol,2005

5. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS);Kurtzke;Neurology,1983

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. How Early Is Early Multiple Sclerosis?;Journal of Clinical Medicine;2023-12-29

2. Predicting disease severity in multiple sclerosis using multimodal data and machine learning;Journal of Neurology;2023-12-22

3. Pathogenic role of autoantibodies at the ependyma in autoimmune disorders of the central nervous system;Frontiers in Cellular Neuroscience;2023-09-13

4. Predicting disease severity in Multiple Sclerosis using multimodal data and machine learning;2023-01-05

5. B-lymphocyte-guided retreatment contributes to establish good effectiveness and safety profile in MS patients treated with rituximab;Multiple Sclerosis and Related Disorders;2022-12